Chapter 5 Correlation between dosage form and generic
Chapter 7: Major Issues Facing the Generic
Table 2: United Kingdom Generics
Market Segmentation I: % Share, by Value, 2004
Apotex - Aspen Pharmacare - Barr Laboratories - Cipla - Dr Reddy's - EGIS - Hospira - KRKA - Lannett - Mayne Pharma - Merck Generics
- Mylan Labs - Par Pharmaceuticals - Perrigo - Pliva - Ranbaxy - ratiopharm - Gedeon Richter - Sandoz - Sawai - Stada Arzneimittel - Teva Pharmaceutical Industries - Towa Pharmaceuticals - Watson Pharmaceuticals - Winthrop - Wockhardt - Zentiva - Zydus Cadila
How likely are physicians to prescribe a generic
version of injectible insulin?
Assess the defensive strategies implemented by branded pharmaceutical marketers to protect their patents and delay generic
entry, and understand how this affects the generics
With increasing regulatory oversight creating transparency around healthcare costs and high-deductible insurance and rising co-payment charges becoming more common, there is an immediate need in the healthcare system for affordable alternatives to existing treatment options," said Ron Bromfield, VP sales and marketing at Generic
Find potential revenues to 2021 for the world generic
drugs market, seeing the possibilities there
manufacturing companies have also been active in mergers and acquisitions, seeking to increase scale, revenue, market reach and competitive advantage.
Federal law and regulations grant a 180-day period of exclusive marketing to the first generic
manufacturer to submit an application for a new generic
Genepharm's experienced regulatory team works closely with the TGA and expects registration for these generic
drugs to be completed beginning in the last quarter of this financial year," said Mr Dennis Bastas, CEO and managing director of Genepharm.
Instead, they were approved by the World Health Organization's well-regarded WHO Prequalification Project, based on bioequivalence data submitted by the companies--the same way generic
medicines are approved for U.
MG: We see MANA in a unique position among generic
In a campaign begun this week, Blue Cross of California, Blue Shield of California, Health Net of California and PacifiCare of California are participating in a program called The Generic
Advantage that is attempting to improve affordability by advocating the use of generic
OTTAWA -- Canadians pay as much as 21 to 51 per cent more for generic
prescription drugs than people living in Western Europe, Australia, New Zealand and in some instances the United States says a report from the federal government prepared by the Patented Medicines Prices Review Board in November 2002.